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Abstract
Purpose Recognizing spinal cord dose limits in various
fractionations is essential to ensure adequate dose for
tumor control while minimizing the chance of radiation-
induced myelopathy (RIM). This study aimed to determine
theα/β ratio of the spinal cord and the cord dose limit in terms
of BED50, the biological equivalent dose (BED) that induces
50 % chance of RIM, by fitting data collected from published
animal and patient studies.
Methods RIM data from five rat studies; three large animal
studies on monkeys, dogs, and pigs; and 18 patient studies
were included for the investigation. The α/β ratios were de-
rived, respectively, for rat (group A), large animal (group B),
patient (group C), and combined data (group D).
Results The α/β ratio (and its 95 % confidental interval) was
4.1 (3.2, 5.0) or 3.6 (2.6, 4.6) Gy for group A, depending on
fitting algorithms. It was 3.9 (3.0, 4.8), 3.7 (2.2, 8.2)
and 3.9 (3.0, 4.9) for groups B, C, and D, respectively.
BED50 was 111Gy for the combined data. It corresponds to a
D50 of 73.4 Gy in 2 Gy/FX, or 19.0 Gy in single fraction.
BED5, which is the BED to induce 5 % of RIM, was calcu-
lated to be 83.9 Gy. It corresponds to D5 of 55.4 Gy in 2 Gy/
FX, or 16.2 Gy in single fraction.
Conclusion The study showed that all four groups had similar
α/β ratios close to 3.9 Gy, suggesting that the spinal cord has a
similar fractionation effect for different species, including hu-
man beings.
Keywords Cord dose tolerance .α/β ratio . Myelopathy .
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Introduction
Radiation-induced myelopathy (RIM) is one of the most se-
vere complications for radiation treatment of cancers in the
neck, thoracic, and abdominal regions. The human spinal cord
was estimated to have a probability of RIM of less than 5 % in
5 years following a dose of 47–50 Gy delivered in a standard
1.8–2Gy/fraction schedule [1, 2]. The spine is also one of the
most frequent sites for metastases. The metastatic tumor often
invades into the spinal cord, compresses the cord, and causes an
emergency, which requires radiation treatment and surgical in-
tervention. A conventional radiation regimen of 30 Gy in 10
fractions is often used to manage patients with cord compres-
sion, preceded or followed by a decompression surgery.
Recently, a radiosurgical decompression approach has been
proposed to manage these patients [3]. In addition, linear
accelerator-based stereotactic radiosurgery (SRS) and stereo-
tactic body radiotherapy (SBRT) have been frequently used to
treat spine metastasis without cord compression [3–5]. A RIM
model that reflects the fractionation effect of the spinal cord is
needed to optimize the radiation dose and fractionation scheme.
The fractionation effect, represented by the α/β ratio in the
linear quadratic model, has been well studied for the spinal
cord on rats [6–10]. These prospective studies showed that the
α/β ratio of the rat spinal cord ranged from 1.8∼4.6 Gy, de-
pending on the site (cervical or lumbar spine) and the study
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[11]. However, applying rat models to humans is intrinsically
complicated because their anatomy and lifespan are quite dif-
ferent from humans. The rat data may also have relatively
large experimental uncertainties due to very narrow radiation
fields used to spare the normal structures. The narrow radia-
tion field usually has a non-flat dose profile across the field.
Thus, even a normal experimental setup uncertainty may in-
duce a relatively large dosimetric uncertainty.
Studies have been carried out on larger animals, such as
dogs, monkeys, and pigs, for the RIM in several different
fractionation schemes 12. However, large animal studies are
expensive. The data from each of these experiments were not
sufficient to derive the α/β ratio. Many retrospective studies
have reported RIM incidences in humans at various cord
doses and fractionations. An α/β ratio of 0.87 Gy, with a
95 % confidence interval (CI) of (0.54, 1.19)Gy was derived
from these limited data for the human cervical spine [12].
However, human data are usually highly limited in power,
because of the rare occurrence and nature of retrospective
documentation. These data are often anecdotal, have limited
number of data points, small range of doses, inconsistent end-
points, and sometimes, inaccurate cord dose calculations. For
these reasons, the α/β ratio derived from these data may be
unreliable.
The aims of this study were to compare the α/β ratios of
the spinal cord between patients and animals by re-analyzing
existing data in the literature, and to develop a RIM model
from the combined data. Because the anatomy and life span
between species is different, the animal data were further sep-
arated into small animal (rat) and large animal groups for
comparison. Several unique approaches were used in the re-
analysis: (1) normalization and non-linear regression were
used to pool all rat data together to increase the statistic power
and reduce the effect of large dosimetric uncertainties; (2) data
of large animal were grouped together to derive an α/β ratio
for this group; and (3) Monte Carlo simulation was used to
correct a potential dosimetric error for one patient study,
which provided the key data for deriving the α/β ratio on
patients.
Material and methods
Data collection and correction
All available animal and patient studies were collected from
literature searches using key words of Bradiation induced my-
elopathy,^, Bradiation, myelopathy,^ Bradiation, spinal cord
complication,^ or Bradiation, spinal cord injury.^ The data
were separated into four groups: (A) small animals, (B) large
animals, (C) patients, and (D) patients and large animals com-
bined. To avoid the confounding effect of dose rate and vol-
ume effects, studies (or data points) with low dose rate
(<0.1 Gy/min) or small volume (<2 vertebral sections) were
excluded. Because of the concern of large dosimetric uncer-
tainties in small animal studies (rats and mice), small animal
data were not included in the combined patient and animal
group, and only those rat studies specifically designed for
studying the fractionation effect were included in the
small animal group. A total of 5 rat [6–10], 3 large animal
[13–15], and 18 patient studies [16–31] were finally included
in this investigation.
The data of five rat studies [6–10] in group Awere shown
in Table 1. They had six data sets, with the corresponding data
points expressed as (D50, n), where D50 is the total dose with
50% of RIM incidence, and n is the fraction number. The data
sets were further separated into the cervical (C) and
thoracicolumber (T/L) spine subgroups. We noted that even
within the same subgroup, there were large variations between
different data sets. Two sources of experimental errors might
contribute to these variations: (1) dose calibration uncertainty
in the small animal experiments and (2) uncorrected quality
factor between kilovolt and megavolt photons. The quality
factor could be up to 1.12 for 50 kV photons [32].
Normalization was performed for these data to reduce the
variations among different studies so they could be analyzed
together. This was based on the assumption that all the rats had
similar radiation response after a single fraction of irradiation,
and the variation among different studies was due to experi-
mental uncertainties (dose calibration and the uncorrected
quality factor). The average D50 value of all data sets at single
fraction was first calculated (it was 22.5 Gy). The normaliza-
tion was accomplished by multiplying a factor for each data
set so that the D50 values at single fraction were all equal to
the average value.
Group B included three animal studies on dogs, monkeys,
and pigs [13–15]. Several data points in the dog and monkey
studies were not included in the analysis because the irradiated
cord length could have been less than two vertebral
sections. As shown in Table 2, the data were presented
as the percentage of RIM (PRIM) incidence, and the irradi-
ated dose per fraction (d) multiplying the number of fractions
(n), or d×n.
The patient data in group C had a total of 25 data points
(RIM data at 25 different fractionation regimens). The data
were also presented as (PRIM, d×n) in Table 2. Among them,
16 data points were from 16 patient studies [16–31] previous-
ly compiled and analyzed for the α/β ratio [12, 35]. These
data were also reviewed in a Quantitative Analysis of Normal
Tissue Effects in the Clinic (QUANTEC) paper [2]. Several of
these studies had more than one data points, and others had the
same dose-fractionation regimen, which were combined into a
single data point. For the 16 data points, 7 were on C-spine,
and 9 on thoracic (T)-spine. The other 9 data points were new
data from a set of patient data collected in four hospitals in
Netherlands [34]. That study reported that 19 of 43 patients
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developed myelopathy in the T spinal cord with the radiation
dose ranging from 43 to 74 Gy, and fraction size ranging from
1.9 to 3.6 Gy/fraction. The 43 patients were divided into nine
groups according to the doses and fractionations. Patient data
from spinal SRS or SBRT [2] were not included in this study
due to the patient setup-related dosimetric uncertainty and the
partial cord volume irradiation.
All the patient data were thoroughly evaluated with the
original sources. Of note, three data points were modified as
a result. Data point 1 was from a report of myelopathy after
radiotherapy of breast cancers [19]. A 22.5 MeV anterior-
posterior electron beam was given to the chest wall and
supraclavicular area. The prescription dose was 25 Gy in 2
fractions. The cord dose was recorded as 19 Gy in 2 fractions.
Table 1 Data points of six data
sets in five studies on rats








Data points (D50 [Gy], fraction [n])
Karger (C) [6] PA 300 4 (24.5, 1); (34.3, 2); (57, 6); (88.6, 18)
Ang (C2-T2) [7] PA 210 4 (22.4, 1); (30.4, 2); (43.4, 4); (63, 10)
Van der Kogel (C) [8] Lateral ∼365 5 (19, 1); (27, 2); (37.8, 5); (55, 10); (80, 30)
White (L) [9] Lateral 365 6 (24, 1); (33, 2); (46, 4); (59, 8); (68, 15);
(92, 30)
Masuda (T) [10] Lateral 455 3 (25.5, 1); (34.5, 2); (46.6, 4)
Van der Kogel (L) [8] Lateral ∼365 7 (19.5, 1); (27, 2); (32.1, 3); (36.8, 5);
(47.7, 10); (60.4, 15); (67.1, 20)
C cervical, T thoracic, L lumber
Table 2 Data points from 3
studies on large animals and 17
studies on patients for the
radiation-induced myelopathy
model
Specie, location Study Data points (PRIM, d (Gy) × n)
Dog, T Powers [14] (3/12, 4×11); (6/12, 4×13); (17/17, 4×17)
(2/12, 2×30); (1/6, 2×34); (3/6, 2×38); (5/6, 2×42)
Monkey, C1-T2 Schultheiss [15] (3/15, 2.2×32); (3/6, 2.2×35); (7/8, 2.2×38);
(6/16, 2.2×32)
Pig, C4-7 Medin [13] (0/5, 16×1); (1/5, 18×1); (4/5, 20×1); (4/4, 22×1);
(4/4, 24×1)
Human, C Reinhold [34] (0/2, 2.1×22); (1/5, 2.1×26); (2/4, 2.2×28);
(5/9, 2.2×30);
(0/2, 2.5×20); (2/4, 2.5×25); (4/6, 2.5×28);
(4/9, 3×21); (2/2, 3.5×18)
Human, C
(QUANTEC)
McCunniff [16] (1/12, 2×30)
Jeremic [17], McCunniff [16] (0/24+0/19, 1.63×40)=(0/43, 1.63×40)
Abbatucci [18] (7/15, 3×18)→excluded from study
Atkins [19] (4/13, 9.5×2)→(4/13, 12×2)





Hazra [21] Choi [22] (1/16+0/75, 3×15)=(1/91, 3×15)
Abramson [23] Fitzgerald [24]
Madden [25] Guthrie [26]
(4/271+6/45+1/43+0/42, 4×10)=(11/401, 4×10)
Dische [27] (13/145, 5.7×6)
Haltlevoll [28] (8/157, 6×3+4×5)
(9/230, 6×3+4×3+2×2)
Eichhorn [29] (8/142, 2.45×27)→(8/46, 2.45×27)
Scruggs [30] (2/248, 4×5+2.5×8)
Macbeth [31] (3/524, 9.2×2)
(2/153, 3.1×13)
PRIM percentage of radiation-induced myelopathy=number of RIM/total number; d dose/fraction, n number of
fractions, C cervical, T thoracic
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However, a Monte Carlo calculation suggested that the
cord dose could be much higher. Figure 1 shows the
dose distribution with Monte Carlo calculation of a
20-MeV electron beam in AP direction delivered to the
same region for a female patient. We noted that the maxi-
mum cord dose was as high as the prescription dose.
Therefore, the cord dose for data point 1 was estimated to be
24 Gy in 2 fractions.
Data point 2 was from Eichhorn et al. [29]. The incidence
of RIMwas first listed as 8/46 [35], but might be subsequently
misquoted as 8/142 in later papers [2, 12]. The correct value,
which is 8/46, was used in our study. Data point 3 was from a
French study [18]. Incidence of RIM was first listed as 8/20
[35] and then 7/15 in later papers [2, 12] for a cord dose of
3-Gy×18. However, there were 94 patients who received a
3 Gy×18 prescription dose in the control group [18].
Because the cord dose of these 94 patients was not
clearly provided, the incidence of RIM for this data point
was difficult to verify and the data point was excluded from
the final analysis.
Data analysis
For group A, a conventional linear regression method [11]
was first used to derive the α/β ratio as well as the
biological equivalent dose (BED) at 50 % of RIM probabil-
ity (BED50). The linear equation was derived directly from a
BED equation,















  ⋅ D50
n
ð2Þ
Equation (2) is a linear function of (1/D50, D50/n). The data
set of (D50, n) was converted into (1/D50, D50/n) for linear
regression analysis. The values of BED50 andα/βwere derived
by best fitting the data into the linear equation. Such analysis
was performed for each data set for the original data, and the
combined data set for each subgroup after normalization.
The linear regression approach had to convert the data point
(D50, n) into (1/D50, D50/n), and thus propagate the large
uncertainty in D50 into both variables. To reduce the effect of
such data conversion, a non-linear regression approachwas also
developed to derive the values of BED50 andα/β. The data set
of (D50, n) was directly fitted into a non-linear equation,





which is the direct solution of Eq. (1).
For groups B, C, and D, the following logistical RIMmodel
was used to fit the data:
PRIM d; nð Þ ¼ 1= 1þ BED50=BEDð Þk
h i
¼ 1= 1þ BED50




Fig. 1 Monte Carlo calculated
dose distribution of an AP
20MeVelectron beam to a female
patient
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It should be noted that for several patient data points, mul-
tiple fractionation regimens were used in a treatment course.
The sum of BED in each fractionation regimen was used for




di⋅ni⋅ 1þ di=α=βð Þ ð5Þ
where di and ni are the dose and fraction number of the ith
regimen, andm is total number of regimens. Three parameters,
α/β, BED50, k, and their corresponding 95 % CI were thus
determined from the fitting program.
Results
Fractionation effect from the rat studies
Figure 2a, b show the original six data sets of the rat studies
(group A) plotted as (1/D50 vs D50/n) for linear regression,
and (D50 vs n) for non-linear regression, respectively.
Figure 2c, d show the same data after normalization, as well
as their linear and non-linear regressions, respectively. The
large inter-study variations in Fig. 2a, b were dramatically
reduced after normalization. The data were clearly separated
into C-spine and T/L-spine subgroups, and the inter-study
variation within each subgroup was comparable to the intra-
study variation.
Table 3 shows the values of α/β ratio and BED50 after
regression analyses. Despite large inter-study variation in the
original data, the α/β ratios were relatively consistent within
each subgroup. The averageα/β ratios were 2.4 and 4.8Gy for
the C-spine and T/L-spine subgroups, respectively, before nor-
malization. They were slightly reduced to 2.2 and 4.1 Gy after
normalization. The overall α/β ratios and their 95 % CI de-
rived from the combined data sets were 2.3 (1.5, 3.0) Gy and
4.1 (3.2, 5.0) Gy, respectively, for the C- and T/L-spine sub-
groups, using the linear regression. They became 2.6 (2.1, 3.2)
Gy and 3.6 (2.6, 4.6) Gy, respectively, using the non-linear
regression. In summary, the α/β ratios were slightly changed
by the normalization and the different regression approaches,
and consequently, the difference in α/β ratios between the two
subgroups (C- and T/L-spines) was reduced, especially using
the non-linear regression. As to be discussed, the smaller α/β
ratio in the C-spine subgroup could be due to shorter follow-up
time. Thus, the values of the T/L-spine subgroup would be
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Fig. 2 Re-analysis of the α/β ra-
tio for the six data sets from five
rat studies specifically designed
for studying fractionation effect
using linear and non-linear
regression. a Original data plotted
(1/D50, D50/n) for linear
regression. bOriginal data plotted
(D50, n) for non-linear regression.
cNormalized data plotted (1/D50,
D50/n) and linear regression of
the combined data for C- and T/L-
spine subgroups. d Normalized
data plotted (D50, n) and non-
linear regression of combined
data sets for the two subgroups
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Fractionation effect from large animal and human data
Figure 3a , b show the plots of the large animal (group B) and
patient data (group C) with the best fitting of the RIM model.
The original data points 1, 2, and 3 before correction were also
shown in Fig. 3b for comparison. The best fitting parameters
and their 95 % CI were α/β=3.9 (3.0, 4.8) Gy, BED50=112
(101, 128) Gy, and k=12 (7.0, 21) for group B; and α/β=3.7
(2.2, 8.2) Gy, BED50=111 (86, 148) Gy, and k=10.4 (5.8,
19.2) for group C. These data were also listed in
Table 4 for comparison between the four groups. The
results suggest that the rats, large animals, and patients
have very similar α/β ratios. We also noted that the patient
data had a large and unbalanced 95 % CI for all parameters.
This is understandable because the data set was unbalanced
for the fractionation size. Only 2 data points had a large
dose/fraction.
RIM model with fractionation effect from the combined
data
Figure 4 shows the plot of the combined patient and large
animal data (group D) with the best fitting of the RIM model.
In addition to the 3 original patient data points before correc-
tion, animal data from two studies on mice [36] and rats [37]
were also presented for comparison. The best fitting parame-
ters and their 95 % CI were α/β=3.9 (3.0, 4.9) Gy, BED50=
111 (101, 120) Gy, and k=10.5 (6.8, 14.2). We noted that
combining the large animal and patient data did not change
the best fitting parameters much, while the 95 % CIs for
BED50 and k were remarkably narrowed, which is essential
for the applicability of the RIM model. We also noted that the
rat and mice data tended to agree with the patient data.
However, although the mice or rat data set was from a single
experiment, the data were more spread out than the patient and
large animal data, possibly due to larger dosimetric uncer-
tainties in small animals.
Table 3 Values ofα/β ratio and BED50 from six data sets in five studies with andwithout normalization. The data were divided into cervical (C)-spine
and thoracicolumber (T/L) spine groups
Subgroup Study Regression Original After normalization
α/β (Gy) BED50 (Gy) α/β (Gy) BED50 (Gy)
C-Spine Karger [6] Linear 2.3 286 1.9 234
Ang [7] Linear 2.3 238 2.1 211
Van der Kogel [8] Linear 2.5 167 2.6 174
Average Linear 2.4 230 2.2 207
Overall Linear NA NA 2.3 (1.5, 3.0) 198 (142, 235)
Overall Non-linear NA NA 2.6 (2.1, 3.2) 178 (153, 203)
T/L-Spine White [9] Linear 4.8 149 3.9 124
Masuda [10] Linear 5.2 149 4.1 117
Van der Kogel [8] Linear 4.3 111 4.3 114
Average Linear 4.8 136 4.1 118
Overall Linear NA NA 4.1 (3.2, 5.0) 119 (100, 138)
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Fig. 3 Fitting the data with a logistic radiation-induced myelopathy
(RIM) model. The data are plotted as percentage of RIM versus BED.
BED was calculated from dose/fraction and number of fractions using the
best fittingα/β ratio. a Large animal data. b Patient data. Data points 1, 2,
and 3 before correction were also plotted for comparison
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Discussion
With the corrections for possible dosimetric and misquotation
errors in patient data, and the normalization of the rat data, we
have determined that the α/β ratios of the spinal cord were
3.6–4.1, 3.9, and 3.7 Gy for small animals (rat), large animals,
and patients, respectively. We have also determined the three
parameters (including their 95 % CI) for a logistic RIMmodel
from the combined data. They were α/β=3.9 (3.0, 4.9) Gy,
BED50=111 (101, 120) Gy, and k=10.5 (6.8, 14.2).
The α/β ratios are similar between different species, in-
cluding human beings. These α/β ratios of 3.6–4.1 Gy, how-
ever, are greater than the previously reported 0.87 Gy [12].
That study had only 7 data points from five patient studies,
including 3 data points with a same percentage of RIM of 0,
and 2 data points in dispute (points 1 and 2 in the current
study). The statistical power was limited when the data set
was fitted to a non-linear equation with three parameters.
The data point 1, which was from the study of breast treatment
with 25 Gy in 2 fractions [19], was the most critical point to
determine theα/β ratio. The change ofα/β ratio from 0.87Gy
of that study to 3.7 Gy of the current study is likely due to the
adjustment of the cord dose from 9.5 to 12 Gyx2. The cord
dose of 12 Gyx2 was estimated based on Monte Carlo simu-
lation in the current study, which is more reliable. The lower
bound of the 95%CI of theα/β ratio for the patient group was
2.2 Gy, which is similar to the 2.0 Gy value commonly used
clinically for isoeffect calculations.
We noted that theα/β ratio was larger, and BED50 smaller,
for the C-spine than the T/L-spine subgroups of the rat studies
(Table 3). However, the C-spine subgroup had a shorter
follow-up time. The latency of radiation myelopathy was re-
ported to have a bimodal distribution peaking at approximate-
ly 9 and 26 months in humans [33]. In rats, the two peaks
correspond to two distinct pathologies, with the first peak
reflecting white matter injury occurring less than 8 months
after radiation exposure, and the second peak reflecting vas-
cular injury occurring between 8 and 18months after radiation
exposure [33]. The latent period depends on the radiation dose
and fraction size [9, 36]. High-dose and single fraction tend to
result in shorter latent periods [9, 36]. Therefore, longer
follow-up time would record more events for lower dose at
larger fraction numbers (n). As shown in Fig. 2d, this would
shift the points of the C-spine subgroup at large n downward,
and thus decrease BED50 and increase α/β ratios. Therefore,
there is a possibility that the larger BED50 and smaller α/β
ratio observed in the C-spine group was attributed to the
shorter follow-up time rather than the anatomic location per
se. The non-linear regression also reduced the difference be-
tween the two subgroups, suggesting that experimental uncer-
tainty may also contribute to it. The patient data for C- and T-
spine was similar, supporting the argument that there is no
difference between the C- and T-spine.
The study showed a BED50 of 111 Gy for the combined
and patient data. It corresponds to a D50 of 73.4 Gy in 2 Gy/
FX, or 19.0 Gy in single fraction. BED5, which is the BED to
induce 5 % of RIM, was calculated to be 83.9 Gy according to
Eq. (4) with k=10.5. It corresponds to D5 of 55.4 Gy in 2 Gy/
FX, or 16.2 Gy in single fraction. However, applying these
data to clinical SBRT is not straightforward due to two factors.
The first factor is the dose volume effect. The cord dose is
Table. 4 Comparison of the
fitting parameters for groups A,
B, C and D
Groups Regression α/β (Gy) BED50 (Gy) k



















































ty Powers, dog, T1-T11, 2-4 Gy/FX
Schultheiss, monkey, C-T, 2.2Gy/FX
Medin, pig, C4-C7, 1 FX









Fig. 4 Fitting the combined (group D) data with a logistic radiation-
induced myelopathy (RIM) model. In addition to the 3 patient data
points before correction, data from mice and rat studies were also
plotted for comparison
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usually not uniform in spinal SRS or SBRT due to the use of
intensity modulated techniques. The cord dose is represented
by the dose volume histogram and has to be converted into an
equivalent uniform dose. The second factor is the setup uncer-
tainty in spinal SRS and SBRT. Even with image guidance,
the combined patient setup uncertainty could have a 5% prob-
ability of being greater than 3 mm due to patient position
deformation, uncorrected rotation errors, and patient move-
ment during treatment [38]. Such setup errors may shift the
cord into a high-dose region due to the sharp dose falloff
between the target and the cord. A RIM model incorporating
the setup uncertainty, similar to the approach used in tumor
control probability model by Jin et al. [39], may be required to
improve the prediction of RIM for spinal SRS or SBRT
patients.
Conclusion
The study suggests that the spinal cord has a similar α/β ratio
for patients, rats and other large animals, such as dogs, mon-
keys, and pigs. Theα/β ratio is close to 3.9 Gy, with a 95%CI
of (3.0, 4.9) for the combined group, and (2.2, 8.2) for the
patient only group.
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